Type 2 Diabetes Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Children who are between 12 and 16 years old
- Children who have obesity, meaning their body mass index (a measure of body weight relative to height) is above the 97th percentile for their age
- Children who are able to give their agreement to take part, confirmed by their signature
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- Children who have diabetes and also test positive for certain proteins in the blood that attack the pancreas (confirm with trial site for exact details on which proteins are tested)
- Children who have a known liver disease, other than a condition called fatty liver disease (NAFLD)
- Children who are currently taking, or have taken within the last two weeks, certain medications for blood sugar control, including tablets for diabetes, GLP-1 injections, or insulin
- Children who are currently taking any medication known to affect how the liver works
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +41 79 55 33 476
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Correlation of 1,5-anhydroglucitol levels in obese children with indirect markers of beta-cell function and mass and with metabolic control; Correlation of 1,5-anhydroglucitol levels in obese children with indirect markers of beta-cell function and mass and with metabolic control
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.